LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Jun 1, 2018
Clinical News
Gilead's Epclusa approved in China for HCV
Read More
BioCentury
|
May 30, 2018
Company News
Gilead's Epclusa approved in China for HCV
Read More
BioCentury
|
Sep 25, 2017
Company News
Gilead's Sovaldi gets Chinese approval
Read More
BioCentury
|
Mar 3, 2017
Company News
Second Ascletis HCV therapy gets expedited CFDA review
Read More
BioCentury
|
Jan 4, 2017
Financial News
Ascletis raises $100M in series B
Read More
BioCentury
|
Dec 30, 2016
Company News
China accepts NDA for Ascletis' HCV candidate
Read More
BioCentury
|
Jun 27, 2016
Clinical News
Ravidasvir: Interim Phase II data
Read More
BioCentury
|
Jun 22, 2016
Clinical News
Ascletis' HCV regimen moving along in Taiwan, China
Read More
BioCentury
|
Apr 26, 2016
Politics & Policy
CFDA names HCV drugs in expedited pathway
Read More
BioCentury
|
Dec 7, 2015
Clinical News
Ravidasvir: Phase III data
Read More
Items per page:
10
1 - 10 of 16
